References
- Foltin R W, Fischman MW. Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Dep 1991; 28: 5–48
- Kosten T R, Rounsaville B J, Kelber HD. A 2.5-year follow-up of cocaine use among opioid addicts. Arch Gen Psychiatry 1987; 44: 281–284
- Kosten T R, Kleber H D, Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 1989; 44: 887–892
- Mello N K, Mendelson J H, Kuehnle JC. Buprenorph-ine effects on human heroin self-administration: an operant analysis. J Pharmacol Exp Ther 1982; 223: 30–39
- Mello N K, Bree M P, Mendelson JH. Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J Pharmacol Exp Ther 1983; 225: 378–386
- Johnson R E, Jaffe J H, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750–2755
- Mello N K, Mendelson JH. Buprenorphine suppresses heroin use by heroin addicts. Science 1980; 207: 657–659
- Mello N K, Mendelson J H, Bree M P, et al. Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science 1989; 245: 859–862
- Mello NK. Preclinical evaluation of the effects of buprenorphine, naltrexone, and desipramine on cocaine self-administration. Problems of Drug Dependence 1990 Proceedings of the 52nd Annual Scientific Meeting., L. Harris. U.S. Department of Health and Human Services, Rockville, MD 1991; 189–195, NIDA Research Monograph, Series 105
- Kosten T A, Marby D W, Nestler EJ. Cocaine-conditioned place preference is attenuated by chronic buprenorphine treatment. Life Sci 1991; 49: 201–206
- Kosten T R, Kleber H D, Morgan C. Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 1989; 26: 637–639
- Kosten T R, Schortenfeld R S, Ziedonis D, et al. Buprenorphine vs. methadone for opiate dependence. J Nov Mem Dis 1993; 181: 358–364
- Marian G A, Gordon JR. Determinants of relapse: implications for the maintenance of behavior change. Behavioral Medicine: Changing Health Lifestyles, PO Davidson, DS. Davidson. Brunner/Mazel, New York 1980; 410–451
- Kosten T R, Rounsaville B J, Kleber HD. Concurrent validity of the Addiction Severity Index. J Nerv Ment Dis 1983; 171: 606–610
- McLellan A T, Luborsky L, O'Brien CP. Improved diagnostic instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168: 26–33
- Gawin F, Kleber HD. Cocaine abuse treatment an open trial with lithium and desipramine. Arch Gen Psychiatry 1984; 41: 903–910
- Schottenfeki R S, Pakes J, Ziedonis D, et al. Buprenorphine dose-related effects on cocaine and opiate use in cocaine-abusing opiate-dependent humans. Biol Psychiatry 1993; 34: 66–74
- Stine S M, Freeman M, Burns B, et al. Effects of methadone dose on cocaine abuse in a methadone program. American Journal on Addictions 1992; 1: 294–303
- Kosten T A, Jacobsen L S, Kosten TR. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-HI-R criteria. Am J Drug Alcohol Abuse 1989; 15: 237–250
- Kosten TA. Cocaine attenuates the severity of naloxone-precipitated opioid withdrawal. Life Sci 1990; 47: 1617–1623
- Stine S M, Satel S, Kosten TR. Cocaine precipitation of patient-identified opiate withdrawal. American Journal on Addictions 1993; 2: 255–258